| Condition |
Code |
| Bone Neoplasms [C05.116.231]
exit? |
OCOSH Code C05.116.231_BD_BN |
| Femoral Neoplasms [C05.116.231.343]
exit? End of Mesh Classification |
OCOSH Code C05.116.231.343_BD_BN_FN |
| Skull Neoplasms
[C05.116.231.754] exit? |
OCOSH Code C05.116.231.754_BD_BN_SN |
| Jaw Neoplasms
[C05.116.231.754.450] exit? |
OCOSH Code C05.116.231.754.450_BD_BN_SN_JN |
|
Mandibular Neoplasms [C05.116.231.754.450.583] exit?
End of Mesh Classification |
OCOSH Code
C05.116.231.754.450.583_BD_BN_SN_JN_MNN |
|
Maxillary Neoplasms [C05.116.231.754.450.601] exit?
End of Mesh Classification |
OCOSH Code
C05.116.231.754.450.601_BD_BN_SN_JN_MXN |
|
Palatal Neoplasms [C05.116.231.754.450.692] exit?
End of Mesh Classification |
OCOSH Code
C05.116.231.754.450.692_BD_BN_SN_JN_PN |
| Nose Neoplasms [C05.116.231.754.600]
exit? End of Mesh Classification |
OCOSH Code C05.116.231.754.600_BD_BN_NN |
| Orbital
Neoplasms [C05.116.231.754.659]
exit? End of Mesh Classification |
OCOSH Code C05.116.231.754.659_BD_BN_ON |
| Skull Base
Neoplasms [C05.116.231.754.829]
exit? End of Mesh Classification |
OCOSH Code C05.116.231.754.829_BD_BN_SBN |
| Spinal Neoplasms [C05.116.231.828]
exit? End of Mesh Classification |
OCOSH Code C05.116.231.828_BD_BN_SPN |
| Musculoskeletal Neoplasms by type |
|
| Lymphoma
[C04.557.386] exit? |
OCOSH Code C04.557.386_BD_BN_L |
| Plasmacytoma
[C04.557.386.720] exit? |
OCOSH Code C04.557.386.720_BD_BN_PL |
| Multiple
Myeloma [C04.557.386.720.550] exit? End of Mesh
Classification |
OCOSH Code C04.557.386.720.550_BD_BN_PL_MM |
| Neoplasms,
Adipose Tissue [C04.557.450.550] exit? |
OCOSH Code C04.557.450.550_BD_BN_AT |
| Angiolipoma
[C04.557.450.550.100] exit? End of Mesh Classification |
OCOSH Code C04.557.450.550.100_BD_BN_AT_AL |
| Angiomyolipoma
[C04.557.450.550.125] exit? End of Mesh Classification |
OCOSH Code C04.557.450.550.125_BD_BN_AT_AML |
| Lipoma
[C04.557.450.550.400] exit? End of Mesh Classification |
OCOSH Code C04.557.450.550.400_BD_BN_AT_L |
| Liposarcoma
[C04.557.450.550.420] + exit? |
OCOSH Code C04.557.450.550.420_BD_BN_AT_LS |
| Myelolipoma
[C04.557.450.550.710] exit? End of Mesh Classification |
OCOSH Code C04.557.450.550.710_BD_BN_AT_ML |
| Neoplasms,
Connective and Soft Tissue [C04.557.450] |
OCOSH Code C04.557.450_BD_BN_CTS |
| Neoplasms,
Connective Tissue [C04.557.450.565] |
OCOSH Code C04.557.450.565_BD_BN_CTS_CT |
| Chondroblastoma
[C04.557.450.565.250] exit? End of Mesh Classification |
OCOSH Code C04.557.450.565.250_BD_BN_CTS_CT_CB |
| Chondroma
[C04.557.450.565.265] + exit? |
OCOSH Code C04.557.450.565.265_BD_BN_CTS_CT_C |
| Chondromatosis
[C04.557.450.565.265.270] exit? End of Mesh
Classification |
OCOSH Code C04.557.450.565.265.270_BD_BN_CTS_CT_C_MC |
| Chondrosarcoma
[C04.557.450.565.280] + exit? |
OCOSH Code C04.557.450.565.280_BD_BN_CTS_CT_CS |
| Chondrosarcoma,
Mesenchymal [C04.557.450.565.280.280] exit? End of Mesh
Classification |
OCOSH Code C04.557.450.565.280.280_BD_BN_CTS_CT_CS_M |
| Giant
Cell Tumors [C04.557.450.565.380] + exit? |
OCOSH Code C04.557.450.565.380_BD_BN_CTS_CT_GCT |
| Giant
Cell Tumor of Bone [C04.557.450.565.380.380] exit? End
of Mesh Classification |
OCOSH Code C04.557.450.565.380.380_BD_BN_CTS_CT_GCT_B |
| Myxoma
[C04.557.450.565.550] + exit? |
OCOSH Code C04.557.450.565.550_BD_BN_CTS_CT_MX |
| Myxosarcoma
[C04.557.450.565.560] exit? End of Mesh Classification |
OCOSH Code C04.557.450.565.560_BD_BN_CTS_CT_MXS |
| Neoplasms,
Bone Tissue [C04.557.450.565.575] exit? |
OCOSH Code C04.557.450.565.575_BD_BN_CTS_CT_B |
| Fibroma,
Ossifying [C04.557.450.565.575.400] exit? End of Mesh
Classification |
OCOSH Code C04.557.450.565.575.400_BD_BN_CTS_CT_B_OF |
| Osteoblastoma
[C04.557.450.565.575.600] exit? End of Mesh
Classification |
OCOSH Code C04.557.450.565.575.600_BD_BN_CTS_CT_B_OB |
| Osteochondroma
[C04.557.450.565.575.610] + exit? |
OCOSH Code C04.557.450.565.575.610_BD_BN_CTS_CT_B_OC |
|
Osteochondromatosis
[C04.557.450.565.575.610.615] exit? |
OCOSH Code C04.557.450.565.575.610.615_BD_BN_CTS_CT_B_OC_O |
| Exostoses,
Multiple Hereditary [C04.557.450.565.575.610.615.325] exit?
End of Mesh Classification |
OCOSH Code C04.557.450.565.575.610.615.325
_BD_BN_CTS_CT_B_OC_O_MHE |
| Osteoma
[C04.557.450.565.575.625] + exit? |
OCOSH Code C04.557.450.565.575.625_BD_BN_CTS_CT_B_OS |
| Osteoma,
Osteoid [C04.557.450.565.575.625.625] exit? End of Mesh
Classification |
OCOSH Code C04.557.450.565.575.625.625_BD_BN_CTS_CT_B_OS_OO |
| Osteosarcoma
[C04.557.450.565.575.650] + exit? |
OCOSH Code C04.557.450.565.575.650_BD_BN_CTS_CT_B_OSC |
| Osteosarcoma,
Juxtacortical [C04.557.450.565.575.650.655] exit? End
of Mesh Classification |
OCOSH Code C04.557.450.565.575.650.655_BD_BN_CTS_CT_B_OSC_J |
| Sarcoma,
Ewing's [C04.557.450.565.575.650.800] exit? End of Mesh
Classification |
OCOSH Code C04.557.450.565.575.650.800
_BD_BN_CTS_CT_B_OSC_EW |
| Neoplasms,
Fibrous Tissue [C04.557.450.565.590] + exit? |
OCOSH Code C04.557.450.565.590_BD_BN_CTS_CT_FT |
| Dermatofibroma
[C04.557.450.565.590.300] + exit? |
OCOSH Code C04.557.450.565.590.300_BD_BN_CTS_CT_FT_D |
| Histiocytoma,
Fibrous [C04.557.450.565.590.300.380] exit? End of Mesh
Classification |
OCOSH Code C04.557.450.565.590.300.380_BD_BN_CTS_CT_FT_D_FH |
| Fibroma
[C04.557.450.565.590.340] + exit? |
OCOSH Code C04.557.450.565.590.340_BD_BN_CTS_CT_FT_F |
| Fibroma,
Desmoplastic [C04.557.450.565.590.340.345] exit? End of
Mesh Classification |
OCOSH Code C04.557.450.565.590.340.345_BD_BN_CTS_CT_FT_F_DF |
| Fibroma,
Ossifying [C04.557.450.565.590.340.360] exit? End of
Mesh Classification |
OCOSH Code C04.557.450.565.590.340.360_BD_BN_CTS_CF_FT_F_OF |
| Fibromatosis,
Aggressive [C04.557.450.565.590.340.410] exit? End of
Mesh Classification |
OCOSH Code C04.557.450.565.590.340.410_BD_BN_CTS_CT_FT_F_AF |
| Fibrosarcoma
[C04.557.450.565.590.350] + exit? |
OCOSH Code C04.557.450.565.590.350_BD_BN_CTS_CT_FT_FS |
| Dermatofibrosarcoma
[C04.557.450.565.590.350.320] exit? End of Mesh
Classification |
OCOSH Code C04.557.450.565.590.350.320_BD_BN_CTS_CT_FT_FS_DF |
| Neurofibrosarcoma
[C04.557.450.565.590.350.590] exit? End of Mesh
Classification |
OCOSH Code C04.557.450.565.590.350.590_BD_BN_CTS_CT_FT_FS_NF |
| Myofibromatosis
[C04.557.450.565.590.550] exit? End of Mesh
Classification |
OCOSH Code C04.557.450.565.590.550_BD_BN_CTS_CT_FT_MF |
| Neoplasms,
Fibroepithelial [C04.557.450.565.590.595] + exit? |
OCOSH Code C04.557.450.565.590.595_BD_BN_CTS_CT_FT_FN |
| Sarcoma,
Clear Cell [C04.557.450.565.800] exit? End of Mesh
Classification |
OCOSH Code C04.557.450.565.800_BD_BN_CTS_CT_CCS |
| Sarcoma,
Small Cell [C04.557.450.565.825] exit? End of Mesh
Classification |
OCOSH Code C04.557.450.565.825_BD_BN_CTS_CT_SCS |
| Sarcoma,
Synovial [C04.557.450.565.835] exit? End of Mesh
Classification |
OCOSH Code C04.557.450.565.835_BD_BN_CTS_CT_SS |
| Neoplasms,
Muscle Tissue [C04.557.450.590] + exit? |
OCOSH Code C04.557.450.590_BD_BN_CTS_MT |
| Granular
Cell Tumor [C04.557.450.590.350] exit? End of Mesh
Classification |
OCOSH Code C04.557.450.590.350_BD_BN_CTS_MT_GC |
| Myoma
[C04.557.450.590.540] exit? |
OCOSH Code C04.557.450.590.540_BD_BN_CTS_MT_M |
| Rhabdomyoma
[C04.557.450.590.540.700] exit? End of Mesh
Classification |
OCOSH Code C04.557.450.590.540.700_BD_BN_CTS_MT_M_RM |
| Myosarcoma
[C04.557.450.590.550] |
OCOSH Code C04.557.450.590.550_BD_BN_CTS_MT_MS |
| Rhabdomyosarcoma
[C04.557.450.590.550.660] + exit? |
OCOSH Code C04.557.450.590.550.660_BD_BN_CTS_MT_MS_RM |
| Sarcoma,
Alveolar Soft Part [C04.557.450.590.775] exit? End of
Mesh Classification |
OCOSH Code C04.557.450.590.775_BD_BN_CTS_MT_ASS |
| Other Sarcoma
[C04.557.450.795] + exit?
|
OCOSH Code C04.557.450.795_BD_BN_CTS_SARC |